About Myhoneypower

Myhoneypower is the U.S. stocking partner for HoneyPower, operating from 345 Seventh Avenue, Floor 16, New York, NY 10001, USA. This desk stocks the product, writes every page on this website, and hands an order over to the seller’s checkout. It did not formulate the capsule and it did not make it.

That separation is the reason this site can be useful. A manufacturer writing about its own product has one set of incentives. A retailer writing about a product it stocks has a different set, and the second set allows a sentence like the one three paragraphs below, which a manufacturer would never print.

The website address cannot see orders. That is a genuine limitation rather than a policy, and it is why the two channels are listed separately everywhere.

HoneyPower is a capsule taken two a day with water, 60 to a bottle, which is about a month. The seller names six botanicals on its own ingredient graphic: honey, Panax ginseng, maca root, tribulus terrestris, horny goat weed and black pepper extract. It gives an amount for none of them.

It is sold for energy, stamina and general male vitality, and the nine benefit lines on the overview panel are support claims about a healthy adult man rather than claims about a condition. It is a dietary supplement rather than a drug, it is not FDA-approved, and the artwork carries the disclaimer saying so.

What makes it an unusual thing to write about is the missing column. Most desks in this estate can set a printed milligram beside a trial milligram and let a reader judge. Here only one side of that comparison exists, and the whole editorial approach on this site follows from that single fact.

A supplement site has to decide in advance how far it will go, because the decision is impossible to make fairly halfway through writing a sales page. The rule here is simple: the ceiling is what the artwork prints, and everything above it is quoted rather than asserted.

In practice that produces three tiers, and a reader can see which tier any sentence on this site belongs to.

Three tiers. Nothing on this site sits above the third, and nothing moves between them.

The third tier carries the rule that does most of the work. A trial of Panax ginseng at three grams a day is evidence about three grams a day of Panax ginseng. It is not evidence about a capsule that contains an unstated quantity of it alongside five other plants, and no sentence on this site treats it as though it were.

A list of refusals is more informative than a list of standards, because a refusal names something a reader could otherwise have expected to find here.

• Any milligram figure for this product. No panel of the artwork carries one, and an estimate dressed as a fact is the commonest defect in this category.
• “Supports healthy testosterone” as an outcome. The seller prints it; this desk quotes it as the seller’s wording. Tribulus was given directly to young men and measured, and androgen production did not change.
• “Improves blood circulation”. Not one of the six has a human circulation endpoint behind it. The nearest thing in the literature is icariin inhibiting PDE5 in glassware.
• The seller’s review score, customer count and recommendation rate, all three of which are higher than the distributor’s own summary.
• The named medical reviewer on the seller’s information site, whose credentials this desk could not confirm.
• Any suggestion that honey raises testosterone. The only record linking the two is a gerbil study, and it is cited as an animal study or not at all.
• A delivery estimate. The pack publishes none, and inventing one is inventing the fact a buyer checks against his own doormat.

Two of those seven cost this site money, and they are the second and the fourth. A testosterone claim and a 4.8-star headline would both sell more capsules than what is printed instead.

Every page here carries the HoneyPower Team byline. It is an organisation, not a person, and that is a deliberate choice rather than an oversight.

A named individual on a supplement page is only worth something if a reader can check him: find the licence, find the institution, find something he wrote elsewhere. The seller’s own information site carries a named reviewer this desk could not check, which is a good demonstration of the problem rather than a solution to it.

So the byline names the desk that is accountable for the page, gives an email address that reaches it, and prints a review date. Those three things can be acted on. A name that cannot be verified cannot.